Cargando…

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database

Few data are available on the clinical impact of drug–drug interactions (DDIs). Most of the studies are limited to the analysis of exposure to potential DDI or the targeted impact of the combination of a few drugs or therapeutic classes. The analysis of adverse drug reaction (ADR) reports could be a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Létinier, Louis, Ferreira, Amandine, Marceron, Alexandre, Babin, Marina, Micallef, Joëlle, Miremont-Salamé, Ghada, Pariente, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024557/ https://www.ncbi.nlm.nih.gov/pubmed/33841134 http://dx.doi.org/10.3389/fphar.2020.624562

Ejemplares similares

Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
por: Martin, Guillaume L., et al.
Publicado: (2022)

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
por: Létinier, Louis, et al.
Publicado: (2021)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
por: Létinier, Louis, et al.
Publicado: (2019)

Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database
por: Courtois, Émeline, et al.
Publicado: (2018)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
por: Soeiro, Thomas, et al.
Publicado: (2021)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Emergency department admissions induced by drug–drug interactions in the elderly: A cross‐sectional study
por: Letinier, Louis, et al.
Publicado: (2022)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database
por: Pueyo-Val, Javier, et al.
Publicado: (2023)

Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database
por: Magro, Lara, et al.
Publicado: (2021)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Hospitalisations après consommation de substances psychoactives pendant la pandémie de COVID-19
por: Dumoulin, Claire, et al.
Publicado: (2023)

Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method
por: Rolland, Anne-Lise, et al.
Publicado: (2021)

Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
por: Noguchi, Yoshihiro, et al.
Publicado: (2020)

Orphandev, French Clinical Trials Network dedicated to Orphan drugs and therapeutics development for rare diseases
por: Adjibi, Yolande, et al.
Publicado: (2010)

Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database
por: Vintila, Bogdan Ioan, et al.
Publicado: (2023)

Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review
por: Gentile, Gaetan, et al.
Publicado: (2020)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
por: Karapetiantz, Pierre, et al.
Publicado: (2018)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
por: Balcerac, Alexander, et al.
Publicado: (2022)

Pharmacovigilance on drugs for headache and pain
Publicado: (2002)

Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
por: Jong, Miek C., et al.
Publicado: (2021)

Myocardial infarction associated with erenumab: A case report
por: Perino, Justine, et al.
Publicado: (2022)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review
por: Bertrand, Valérie, et al.
Publicado: (2021)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
por: Jo, Hyeong-Geun, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
por: Choi, Jung-Yoon, et al.
Publicado: (2021)

Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
por: Pozsgai, Kevin, et al.
Publicado: (2022)

Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases
por: Contreras-Salinas, Homero, et al.
Publicado: (2022)

Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit
por: Salvador, Mário Rui, et al.
Publicado: (2022)

Angioedema Caused by Drugs That Prevent the Degradation of Vasoactive Peptides: A Pharmacovigilance Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0lo0qpvtha82kp5blr5d0g6khh